Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30028376HIVENSG00000213341.11protein_codingCHUKNoNo1147O15111
TVIS30028377HIVENSG00000213341.11protein_codingCHUKNoNo1147O15111
TVIS30028378HIVENSG00000213341.11protein_codingCHUKNoNo1147O15111
TVIS30028379HIVENSG00000213341.11protein_codingCHUKNoNo1147O15111
TVIS44034669HTLV-1ENSG00000213341.11protein_codingCHUKNoNo1147O15111
TCGA Plot Options
Drug Information
GeneCHUK
DrugBank IDDB00795
Drug NameSulfasalazine
Target IDBE0004655
UniProt IDO15111
Regulation Type
PubMed IDs9486988; 11054378; 11151876; 12950415
CitationsWahl C, Liptay S, Adler G, Schmid RM: Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest. 1998 Mar 1;101(5):1163-74. doi: 10.1172/JCI992.@@Weber CK, Liptay S, Wirth T, Adler G, Schmid RM: Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology. 2000 Nov;119(5):1209-18.@@Bantel H, Berg C, Vieth M, Stolte M, Kruis W, Schulze-Osthoff K: Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol. 2000 Dec;95(12):3452-7.@@Allgayer H: Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease. Aliment Pharmacol Ther. 2003 Sep;18 Suppl 2:10-4.
GroupsApproved
Direct ClassificationAzobenzenes
SMILESOC(=O)C1=CC(=CC=C1O)N=NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1
Pathways
PharmGKBPA451547
ChEMBLCHEMBL421